Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$540.70M$540.70Mderived−14.1% vs Q4 2024 Net Income-$15.73M-$15.73MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$202,985,000−10.7% Operating Incomederived$5,635,000−85.0% Operating Cash Flowderived$60,599,000+50.8% Free Cash Flowderived$35,953,000+123.2% Margins · derivedGross margin37.5%+1.5 pt vs Q4 2024
Operating margin1.0%−4.9 pt vs Q4 2024
Net margin-2.9%+0.9 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 19, 2026 · 50 d after period end